ctrl K

AI Score

Unlock

Reviva Pharmaceuticals I... (RVPH)

AI Score

Unlock

1.44

0.01 (0.70%)

At close: Feb 28, 2025, 3:59 PM

1.44

0.35%

After-hours: Feb 28, 2025, 05:20 PM EST

Reviva Pharmaceuticals Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	724.74K	n/a	n/a
Gross Profit	n/a	n/a	n/a	-724.74K	n/a	n/a
Operating Income	-39,503.6B	-24.31M	-10.1M	-2.43M	-376.86K	-1.12M
Interest Income	n/a	182.8K	n/a	105.18K	201.00	n/a
Pretax Income	-39.24M	-24.32M	-8.52M	-3.78M	-846.03K	-1.68M
Net Income	-39,260.8B	-24.34M	-8.52M	-3.78M	-846.83K	-1.68M
Selling & General & Admin	8,083.8B	5.36M	5.25M	2.14M	181.12K	175.58K
Research & Development	31,419.8B	18.95M	4.85M	295.15K	195.74K	946.3K
Other Expenses	n/a	n/a	n/a	n/a	n/a	-0.00
Operating Expenses	39,503.6B	24.31M	10.1M	2.43M	376.86K	1.12M
Interest Expense	n/a	182.8K	2.41K	1.45M	469.37K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	39.5M	24.31M	10.1M	2.43M	376.86K	1.12M
Income Tax	-16.95B	20.78K	6K	800.00	800.00	800.00
Shares Outstanding (Basic)	23.8M	19.52M	14.79M	3.06M	2.77M	n/a
Shares Outstanding (Diluted)	23.8M	19.52M	14.79M	3.06M	2.77M	n/a
EPS (Basic)	-1.65	-1.25	-0.58	-1.24	-0.31	n/a
EPS (Diluted)	-1.65	-1.25	-0.58	-1.24	-0.31	n/a
EBITDA	-39,503.6B	-24.11M	-10.1M	-2.33M	-376.01K	-1.12M
Depreciation & Amortization	n/a	194.71K	236.56K	105.77K	846.00	1.02K